Skip to main content

Table 4 Influence of illness perception on RA disease activity, pain and fatigue over 12 months

From: Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial

  Crude Adjusteda
β (95%CI) p value β (95%CI) p value
Average scores (0, 6 and 12 months)
DAS28-ESR 0.01 (−0.001, 0.02) 0.088 0.007 (−0.01, 0.02) 0.306
Pain 0.73 (0.50, 0.96) <0.001 0.62 (0.36, 0.88) <0.001
Fatigue 0.96 (0.68, 1.24) <0.001 0.51 (0.20, 0.82) 0.001
12-month outcomes
  Crude
Odds ratio (95%CI)
p value Adjusteda
Odds ratio (95%CI)
p value
Remission DAS28-ESR (<2.6) 1.00 (0.97, 1.03) 0.969 1.01 (0.96, 1.03) 0.808
Change in pain (≥10 units) 1.01 (0.98, 1.03) 0.667 1.00 (0.98, 1.02) 0.642
Change in fatigue (≥10 units) 1.01 (0.99, 1.04) 0.353 1.02 (0.98, 1.04) 0.387
  1. aAdjustment for age, gender, ethnicity, disease duration, NHS region and trial arm